This law firm has not supplied any contact details or supplementary information for this country or region. For more information about profiling options please contact Prin Shasiharan.
Joran Michiels of IPSILON Belgium examines how recent EPO and UPC decisions may support inventive-step arguments for CARs, ADCs, bispecific antibodies, and other next-generation therapeutics
